For business leaders, corporate strategists, and growth-focused teams – this report delivers deep market intelligence, forecasts, segmentation, and competitor insights to guide your decisions through 2034.
How has the intracranial hemorrhage devices grown historically, and what trends indicate future expansion?
The intracranial hemorrhage devices market size has grown strongly in recent years. It will grow from $1.71 billion in 2024 to $1.80 billion in 2025 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to increasing incidences of hemorrhagic conditions, supportive government initiatives, supportive healthcare policies, rising prevalence of lifestyle diseases, and rising neurological specialty clinics.
The intracranial hemorrhage devices market size is expected to see strong growth in the next few years. It will grow to $2.22 billion in 2029 at a compound annual growth rate (CAGR) of 5.3%. The growth in the forecast period can be attributed to the rising prevalence of traumatic injuries, focus on reducing hospital stays, increasing adoption of wearable monitoring devices, rising demand for personalized medicine, and increasing use of robotics. Major trends in the forecast period include the development of portable devices, advancements in imaging devices, advancements in monitoring devices, the emergence of 3D printing technology, and the integration of machine learning for medical imaging.
Download Your Free Sample PDF:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20855&type=smp
Which key factors are driving the expansion of the intracranial hemorrhage devices industry?
The rising cases of brain disorders are expected to propel the growth of the intracranial hemorrhage devices market going forward. Brain disorders refer to a wide range of conditions that affect the structure, function, or chemistry of the brain, leading to disruptions in normal brain processes. The cases of brain disorders are increasing due to factors such as improved diagnostics, aging populations, lifestyle changes, and greater awareness, along with rising stress. Intracranial hemorrhage devices are used to detect, monitor, and treat brain disorders involving bleeding by identifying hemorrhages, managing pressure, and removing blood clots to prevent further brain damage. For instance, in October 2022, according to the National Institutes of Health, a US-based government agency, in the US, the estimated number of new cases of primary brain and other CNS tumors was 93,470 in 2022, rising to 94,390 in 2023. Therefore, the rising cases of brain disorders drive the growth of the intracranial hemorrhage devicesmarket.
How is the intracranial hemorrhage devices market segmented by product, application, and end-user?
The intracranial hemorrhage devices market covered in this report is segmented –
1) By Product Type: Diagnosis, Treatment
2) By Devices: Invasive, Non-Invasive
3) By End Users: Hospitals, Ambulatory Surgical Centres, Other End Users
Subsegments:
1) By Diagnosis: MRI (Magnetic Resonance Imaging) Devices, CT (Computed Tomography) Scanners, Ultrasound Devices, EEG (Electroencephalogram) Devices, Intracranial Pressure Monitors, Blood Gas Analyzers
2) By Treatment: Surgical Instruments (Craniotomy Instruments), Drainage Devices (Ventriculostomy Catheters), Embolization Devices, Hemostatic Agents, Coagulation Devices, Neurostimulation Devices
View The Full Market Report:
Which sustainability trends are emerging in the intracranial hemorrhage devices market?
Major companies operating in the intracranial hemorrhage devices market are focusing on developing innovative products, such as advanced neuro access devices, to enhance the precision and efficiency of diagnosing and treating brain injuries. Advanced neuro access devices refer to specialized medical tools and technologies designed to facilitate precise access to the brain or nervous system for diagnostic, surgical, or therapeutic purposes. For instance, in June 2024, Penumbra Inc., a US-based medical device company, announced the European launch of its advanced neuro access devices, BMX81 and BMX96. These devices, designed for managing ischemic and hemorrhagic strokes, incorporate innovative laser-cut stainless steel hypotube technology to improve stability and trackability, while enabling larger inner diameters. This launch highlights Penumbra’s commitment to enhancing stroke care in Europe.
Which leading companies are dominating the intracranial hemorrhage devices market landscape?
Major companies operating in the intracranial hemorrhage devices market are Johnson & Johnson Services Inc., Medtronic Inc., Siemens Healthcare GmbH, Stryker Corporation, General Electric Company, Terumo Corporation, Canon Medical Systems Corporation, Penumbra Inc., MicroPort Scientific Corporation, Aidoc Medical Ltd., Viz.ai Inc., Phenox GmbH, RAPID AI Inc., Acandis GmbH, Kaneka Medix Corporation, Hyperfine Inc., ClearMind Biomedical Inc., InfraScan Inc., Schindler Endoskopie Technologie GmbH, Sense Neuro Diagnostics Inc., MaxQ AI Inc., Invamed Inc.
Which geographic areas are expected to offer the highest growth opportunities in theintracranial hemorrhage devices market?
North America was the largest region in the intracranial hemorrhage devices market in 2024. The regions covered in the intracranial hemorrhage devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Can Companies Use The Intracranial Hemorrhage Devices Market Report to Drive Business Results?
This report provides actionable insights tailored for business use—not academic analysis. Companies can leverage the data to:
• Time market entry or expansion using growth forecasts and CAGR trends.
• Develop competitive products by tracking key technology shifts and user preferences.
• Tailor regional strategies with in-depth geographic data and local market dynamics.
• Benchmark and plan partnerships using competitive landscape insights.
Purchase The Report And Get A Swift Delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20855
Need Customized Data On Intracranial Hemorrhage Devices Market?
For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you’re entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
Request Customized Data:
https://www.thebusinessresearchcompany.com/customise?id=20855&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
